Cargando…

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy

BACKGROUND: Activation of the renin–angiotensin–aldosterone system (RAAS) is an important mediator of diabetic nephropathy. Urinary angiotensinogen, a novel biomarker of the intrarenal RAAS, is associated with progressive kidney injury. In this study, the authors investigated the determinants of uri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satirapoj, Bancha, Siritaweesuk, Nuttawut, Supasyndh, Ouppatham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377805/ https://www.ncbi.nlm.nih.gov/pubmed/25852909 http://dx.doi.org/10.1093/ckj/sfu059

Ejemplares similares

Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial
por: Siriwattanasit, Narongrit, et al.
Publicado: (2021)

Periostin as a Tissue and Urinary Biomarker of Renal Injury in Type 2 Diabetes Mellitus
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study
por: Satirapoj, Bancha, et al.
Publicado: (2016)

Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
por: Yongwatana, Kachonsak, et al.
Publicado: (2020)

Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: a randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2019)

Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study
por: Singhsakul, Amol, et al.
Publicado: (2019)

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Efficacy and safety of subcutaneous administration of lyophilized powder of alfa-erythropoietin to maintain hemoglobin concentrations among hemodialysis patients
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Very low protein diet plus ketoacid analogs of essential amino acids supplement to retard chronic kidney disease progression
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Arterial Stiffness Predicts Rapid Decline in Glomerular Filtration Rate Among Patients with High Cardiovascular Risks
por: Satirapoj, Bancha, et al.
Publicado: (2020)

Impaired Glomerular Filtration Rate in Type 2 Diabetes Mellitus Subjects: A Nationwide Cross-Sectional Study in Thailand
por: Nata, Naowanit, et al.
Publicado: (2020)

Clinicopathological Correlation in Asian Patients with Biopsy-Proven Lupus Nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Tubulointerstitial Biomarkers for Diabetic Nephropathy
por: Satirapoj, Bancha
Publicado: (2018)

Electrolyte disturbances and risk factors of acute kidney injury patients receiving dialysis in exertional heat stroke
por: Satirapoj, Bancha, et al.
Publicado: (2016)

The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease
por: Satirapoj, Bancha, et al.
Publicado: (2015)

Efficacy of Lactulose versus Senna Plus Ispaghula Husk Among Patients with Pre-Dialysis Chronic Kidney Disease and Constipation: A Randomized Controlled Trial
por: Nata, Naowanit, et al.
Publicado: (2021)

The effect of ONCE Renal on minerals and electrolytes in predialysis patients with chronic kidney disease
por: Satirapoj, Bancha, et al.
Publicado: (2016)

Efficacy of Weekly Split versus Single Doses of Ergocalciferol on Serum 25-Hydroxyvitamin D among Patients on Continuous Ambulatory Peritoneal Dialysis: A Randomized Controlled Trial
por: Nata, Naowanit, et al.
Publicado: (2021)

Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population
por: Satirapoj, Bancha, et al.
Publicado: (2013)

Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease
por: Nata, Naowanit, et al.
Publicado: (2023)

Urinary Angiotensinogen as a Biomarker of Nephropathy in Childhood
por: Urushihara, Maki, et al.
Publicado: (2011)

Nutritional status among peritoneal dialysis patients after oral supplement with ONCE dialyze formula
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Comprehensive approach to diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Effect of Vitamin D on Urinary Angiotensinogen Level in Early Diabetic Nephropathy
por: Mahapatra, Himansu Sekhar, et al.
Publicado: (2021)

The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2018)

Correction to: The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2019)

Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes
por: Soltysiak, Jolanta, et al.
Publicado: (2014)

Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia
por: Valias, Gabriela Ribeiro, et al.
Publicado: (2022)

Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy
por: Takamatsu, Masanori, et al.
Publicado: (2008)

The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules
por: Ohashi, Naro, et al.
Publicado: (2019)

Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease
por: Satirapoj, Bancha, et al.
Publicado: (2018)

Urinary Angiotensinogen Is Elevated in Patients with Nephrolithiasis
por: Sun, Wei, et al.
Publicado: (2014)

Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes
por: Terami, Takahiro, et al.
Publicado: (2013)

Association between angiotensinogen T174M polymorphism and the risk of diabetic nephropathy: A meta-analysis
por: Liu, Nina, et al.
Publicado: (2019)

Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy
por: Kamiyama, Masumi, et al.
Publicado: (2013)

EEG Delta/Theta Ratio and Microstate Analysis Originating Novel Biomarkers for Malnutrition-Inflammation Complex Syndrome in ESRD Patients
por: Jatupornpoonsub, Tirapoot, et al.
Publicado: (2022)

Background Activity Findings in End-Stage Renal Disease With and Without Comorbid Diabetes: An Electroencephalogram Study
por: Jatupornpoonsub, Tirapoot, et al.
Publicado: (2021)

Urinary conjugated α-tocopheronolactone—a biomarker of oxidative stress in children with type 1 diabetes
por: Sharma, Gayatri, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4r5h55n807v0pn026ejh2akkcd